Equity Research Accolades
Raymond James’ Equity Research department distinguishes itself in the industry through our:
Preeminent Analysts – Our research analysts average more than 15 years of experience. Many of our analysts have earned national accolades for their work and been recognized in surveys conducted by The Wall Street Journal, Thomson Reuters/StarMine, Forbes, and Institutional Investor over the course of their careers.
Premier Recommendations – Raymond James & Associates (U.S.) has been recognized in both the financial news media and the investment community for the overall performance of its stock recommendations, particularly its Analysts’ Best Picks List®.
- Raymond James’ Analysts’ Best Picks List®, an annual release detailing the single best stock pick for the upcoming year of our participating senior analysts, has outperformed the S&P 500 17 of the 21 years it has been published1.
- Overall, our Strong Buy recommendations have in aggregate outperformed the S&P 500 over the last five years2.
We believe these individual and stock-picking accolades underscore our proven commitment to providing superior investment opportunities for our clients.
It should not be assumed that recommendations made in the future will be profitable or will equal the performance of the securities on these lists. Individual investor results will vary and achieving similar performance figures is unlikely. The Wall Street Journal, Forbes, and Institutional Investor do not sponsor, endorse, or approve Raymond James’ investment programs.
Investing involves risk and you may incur a profit or a loss. International investing involves additional risks such as currency fluctuations, differing financial accounting standards, and possible political and economic instability. Investing in small-cap and mid-cap stocks involves greater risks including greater price volatility, reduced liquidity, and a greater threat of competition.
1Since 1996 a total of 268 stocks have been recommended through the RJ&A Analysts’ Best Picks®. Of these175 advanced (65%) and 93 declined (35%) within the recommended holding period. Performance is calculated on a total return basis with performances averaged, as if an equal dollar allocation was made to each stock at the beginning of the period and held until December 31 of the following year.
2 During the past five years (through year-end 2017) a total of 1,267 stocks have been recommended through the RJ&A Strong Buy recommendations. Of these 766 advanced and 400 declined within the recommended holding period.
The overall market as measured by the S&P 500 has returned an annual average of 12% during the period 12/12/1995 – 12/29/2017, assuming gross dividends are reinvested into the index. The S&P 500 is an unmanaged index of 500 widely held stocks that is generally considered representative of the U.S. stock market. You cannot invest directly in this index.
An investor would incur commissions (and interest charges if transacted in a margin account) to transact these recommendations. The results presented should not and cannot be viewed as an indicator of future performance. Individual results will vary and transaction costs related to investing in these stocks will affect overall performance.
There is no assurance that the Analysts’ Best Picks® or Strong Buy-rated recommendations will achieve the results expected and investors may incur profits or losses. A complete record of all Analysts’ Best Picks® since 1996 and Strong Buy recommendations over the last five years is available upon request.